Product Code: GVR-4-68040-598-5
Microsutures Market Summary
The global microsutures market size valued at USD 0.31 billion in 2024 and projected to reach USD 0.38 billion by 2030, growing at a CAGR of 3.31% from 2025 to 2030. This market growth is largely attributed to the advancements in minimally invasive surgical techniques, increasing prevalence of chronic diseases requiring precise wound management, and an increase in medical tourism.
The growing demand for cosmetic and reconstructive surgeries further propels the adoption of microsutures due to their ability to facilitate fine, less noticeable stitches, leading to better aesthetic outcomes. In addition, technological innovations in suture materials, such as biodegradable and high-strength sutures, enhance the efficiency and safety of procedures, encouraging their widespread use. The growing number of surgical procedures, mainly cosmetic and plastic surgeries, has resulted in fueling the market demand. For instance, according to the data published by the Global Survey 2023, Liposuction was the most common surgery in 2023, with over 2.2 million, followed by breast augmentation, eyelid surgery, abdominoplasty, and rhinoplasty. All these increased procedures directly influence the demand for sutures, which play a significant role in wound closure and post-surgery recovery.
Beyond cosmetic surgeries, the demand for sutures is also propelled by essential medical procedures such as cesarean sections, orthopedic surgeries, and Cardiovascular Surgery interventions, further expanding the market's growth potential.
Global Microsutures Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2030. For this study, Grand View Research has segmented the global microsutures market report based on product, surgery, end use, material, and region.
- Product Outlook (Revenue, USD Million, 2025 - 2030)
- Absorbable
- Non-absorbable
- Surgery Outlook (Revenue, USD Million, 2025 - 2030)
- General Surgery
- Ophthalmology
- Plastic and Reconstructive Surgery
- Neurosurgery
- Cardiovascular Surgery
- Transplantation
- Gynecological Surgery
- Others
- End Use Outlook (Revenue, USD Million, 2025 - 2030)
- Hospitals
- Ambulatory Surgery Center (ASC)
- Specialty Clinics
- Ophthalmic and Eye Surgery Clinics
- Plastic and Reconstructive Surgery Clinics
- Fertility Clinics
- Dental Clinics
- Others
- Material Outlook (Revenue, USD Million, 2025 - 2030)
- Nylon
- Polyglycolic Acid (PGA)
- Polydioxanone
- Others
- Regional Outlook (Revenue, USD Million, 2025 - 2030)
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Kuwait
- UAE
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Surgery
- 1.2.3. End Use
- 1.2.4. Material
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product and Surgery outlook
- 2.2.2. End Use and Material outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Global Microsutures Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Global Microsutures Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. Pricing Analysis
- 3.3.4. Pipeline Analysis
Chapter 4. Global Microsutures Market: Product Estimates & Trend Analysis
- 4.1. Global Microsutures Market: Product Dashboard
- 4.2. Global Microsutures Market: Product Movement Analysis
- 4.3. Global Microsutures Market by Product, Revenue
- 4.4. Absorbable
- 4.4.1. Absorbable market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Non-Absorbable
- 4.5.1. Non-absorbable market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Global Microsutures Market: Surgery Estimates & Trend Analysis
- 5.1. Global Microsutures Market: Surgery Dashboard
- 5.2. Global Microsutures Market: Surgery Movement Analysis
- 5.3. Global Microsutures Market by Surgery, Revenue
- 5.4. General Surgery
- 5.4.1. General surgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Ophthalmology
- 5.5.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Plastic and reconstructive surgery
- 5.6.1. Plastic and reconstructive surgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Neurosurgery
- 5.7.1. Neurosurgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.8. Cardiovascular surgery
- 5.8.1. Cardiovascular surgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.9. Transplantation
- 5.9.1. Transplantation market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.10. Gynecological Surgery
- 5.10.1. Gynecological Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.11. Others
- 5.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Global Microsutures Market: End Use Estimates & Trend Analysis
- 6.1. Global Microsutures Market: End Use Dashboard
- 6.2. Global Microsutures Market: End Use Movement Analysis
- 6.3. Global Microsutures Market by End Use, Revenue
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Ambulatory Surgery Center (ASC)
- 6.5.1. Ambulatory Surgery Center (ASC) market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Specialty Clinics
- 6.6.1. Ophthalmic and Eye Surgery Clinics
- 6.6.1.1. Ophthalmic and eye surgery clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.2. Fertility Clinics
- 6.6.2.1. Fertility clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.3. Plastic and Reconstructive Surgery Clinics
- 6.6.3.1. Plastic and reconstructive surgery clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.4. Dental Clinics
- 6.6.4.1. Dental clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Others
- 6.7.1.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Global Microsutures Market: Material Estimates & Trend Analysis
- 7.1. Global Microsutures Market: Material Dashboard
- 7.2. Global Microsutures Market: Material Movement Analysis
- 7.3. Global Microsutures Market by Material, Revenue
- 7.4. Nylon
- 7.4.1. Nylon market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5. Polyglycolic Acid (PGA)
- 7.5.1. Polyglycolic Acid (PGA) market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Polydioxanone
- 7.6.1. Polydioxanone market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7. Others
- 7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Global Microsutures Market: Regional Estimates & Trend Analysis, By Product, Surgery, and End Use
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 8.3. North America
- 8.3.1. U.S.
- 8.3.1.1. Key country dynamics
- 8.3.1.2. Regulatory framework/ reimbursement structure
- 8.3.1.3. Competitive scenario
- 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.3.2. Canada
- 8.3.2.1. Key country dynamics
- 8.3.2.2. Regulatory framework/ reimbursement structure
- 8.3.2.3. Competitive scenario
- 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.3.3. Mexico
- 8.3.3.1. Key country dynamics
- 8.3.3.2. Regulatory framework/ reimbursement structure
- 8.3.3.3. Competitive scenario
- 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Regulatory framework/ reimbursement structure
- 8.4.1.3. Competitive scenario
- 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Regulatory framework/ reimbursement structure
- 8.4.2.3. Competitive scenario
- 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.3. France
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Regulatory framework/ reimbursement structure
- 8.4.3.3. Competitive scenario
- 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.4. Italy
- 8.4.4.1. Key country dynamics
- 8.4.4.2. Regulatory framework/ reimbursement structure
- 8.4.4.3. Competitive scenario
- 8.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.5. Spain
- 8.4.5.1. Key country dynamics
- 8.4.5.2. Regulatory framework/ reimbursement structure
- 8.4.5.3. Competitive scenario
- 8.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.6. Norway
- 8.4.6.1. Key country dynamics
- 8.4.6.2. Regulatory framework/ reimbursement structure
- 8.4.6.3. Competitive scenario
- 8.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.7. Sweden
- 8.4.7.1. Key country dynamics
- 8.4.7.2. Regulatory framework/ reimbursement structure
- 8.4.7.3. Competitive scenario
- 8.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Key country dynamics
- 8.4.8.2. Regulatory framework/ reimbursement structure
- 8.4.8.3. Competitive scenario
- 8.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.5.2. China
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.5.3. India
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework/ reimbursement structure
- 8.5.3.3. Competitive scenario
- 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.5.4. Australia
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Regulatory framework/ reimbursement structure
- 8.5.4.3. Competitive scenario
- 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Regulatory framework/ reimbursement structure
- 8.5.5.3. Competitive scenario
- 8.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.5.6. Thailand
- 8.5.6.1. Key country dynamics
- 8.5.6.2. Regulatory framework/ reimbursement structure
- 8.5.6.3. Competitive scenario
- 8.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework/ reimbursement structure
- 8.6.1.3. Competitive scenario
- 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.6.2. Argentina
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework/ reimbursement structure
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.7. MEA
- 8.7.1. South Africa
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework/ reimbursement structure
- 8.7.1.3. Competitive scenario
- 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.7.2. Saudi Arabia
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework/ reimbursement structure
- 8.7.2.3. Competitive scenario
- 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.7.3. UAE
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework/ reimbursement structure
- 8.7.3.3. Competitive scenario
- 8.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
- 8.7.4. Kuwait
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework/ reimbursement structure
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company market share analysis, 2024
- 9.3.4. Corza Medical
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Product benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. Baxter
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Product benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. AD Surgical
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Product benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. Ethicon (Johnson & Johnson)
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Product benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. Kono Seisakusho Group
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Product benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. Suturex
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Product benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. AROSurgical Instruments
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Product benchmarking
- 9.3.10.4. Strategic initiatives
- 9.3.11. Bear Medic Corporation
- 9.3.11.1. Company overview
- 9.3.11.2. Financial performance
- 9.3.11.3. Product benchmarking
- 9.3.11.4. Strategic initiatives
- 9.3.12. Altomed
- 9.3.12.1. Company overview
- 9.3.12.2. Financial performance
- 9.3.12.3. Product benchmarking
- 9.3.12.4. Strategic initiatives